Pulmonary hypertension in systemic lupus erythematosus

Report of four cases and review of the literature

H. Daniel Perez, Neil Kramer

Research output: Contribution to journalReview article

78 Citations (Scopus)

Abstract

Pulmonary hypertension has been reported rarely in patients with systemic lupus erythematosus (SLE). During the past 3 1 2 yr we have observed pulmonary hypertension as a major clinical manifestation of their disease in four of 43 patients with well-documented SLE followed at our institution. Pulmonary hypertension could be atrributed to underlying lung disease in three and was considered to be primary in the remaining patient. Neither hydralazine nor prednisone administration had any effect on the course of the pulmonary hypertension in these patients. The presence of pulmonary hypertension in the course of active SLE may be more common than previously recognized.

Original languageEnglish (US)
Pages (from-to)177-181
Number of pages5
JournalSeminars in Arthritis and Rheumatism
Volume11
Issue number1
DOIs
StatePublished - Jan 1 1981
Externally publishedYes

Fingerprint

Pulmonary Hypertension
Systemic Lupus Erythematosus
Hydralazine
Prednisone
Lung Diseases

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine
  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this

@article{d0b38febb3754599afa0ae47a8e7a2d1,
title = "Pulmonary hypertension in systemic lupus erythematosus: Report of four cases and review of the literature",
abstract = "Pulmonary hypertension has been reported rarely in patients with systemic lupus erythematosus (SLE). During the past 3 1 2 yr we have observed pulmonary hypertension as a major clinical manifestation of their disease in four of 43 patients with well-documented SLE followed at our institution. Pulmonary hypertension could be atrributed to underlying lung disease in three and was considered to be primary in the remaining patient. Neither hydralazine nor prednisone administration had any effect on the course of the pulmonary hypertension in these patients. The presence of pulmonary hypertension in the course of active SLE may be more common than previously recognized.",
author = "Perez, {H. Daniel} and Neil Kramer",
year = "1981",
month = "1",
day = "1",
doi = "10.1016/0049-0172(81)90098-6",
language = "English (US)",
volume = "11",
pages = "177--181",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "1",

}

Pulmonary hypertension in systemic lupus erythematosus : Report of four cases and review of the literature. / Perez, H. Daniel; Kramer, Neil.

In: Seminars in Arthritis and Rheumatism, Vol. 11, No. 1, 01.01.1981, p. 177-181.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pulmonary hypertension in systemic lupus erythematosus

T2 - Report of four cases and review of the literature

AU - Perez, H. Daniel

AU - Kramer, Neil

PY - 1981/1/1

Y1 - 1981/1/1

N2 - Pulmonary hypertension has been reported rarely in patients with systemic lupus erythematosus (SLE). During the past 3 1 2 yr we have observed pulmonary hypertension as a major clinical manifestation of their disease in four of 43 patients with well-documented SLE followed at our institution. Pulmonary hypertension could be atrributed to underlying lung disease in three and was considered to be primary in the remaining patient. Neither hydralazine nor prednisone administration had any effect on the course of the pulmonary hypertension in these patients. The presence of pulmonary hypertension in the course of active SLE may be more common than previously recognized.

AB - Pulmonary hypertension has been reported rarely in patients with systemic lupus erythematosus (SLE). During the past 3 1 2 yr we have observed pulmonary hypertension as a major clinical manifestation of their disease in four of 43 patients with well-documented SLE followed at our institution. Pulmonary hypertension could be atrributed to underlying lung disease in three and was considered to be primary in the remaining patient. Neither hydralazine nor prednisone administration had any effect on the course of the pulmonary hypertension in these patients. The presence of pulmonary hypertension in the course of active SLE may be more common than previously recognized.

UR - http://www.scopus.com/inward/record.url?scp=0019798993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019798993&partnerID=8YFLogxK

U2 - 10.1016/0049-0172(81)90098-6

DO - 10.1016/0049-0172(81)90098-6

M3 - Review article

VL - 11

SP - 177

EP - 181

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 1

ER -